Sign in

CIK 0001682852

  • Large accelerated filer

Moderna, Inc.

Sign in to watch
Ticker
MRNA
Exchange
Nasdaq
Industry
Biological Products, (No Diagnostic Substances)
FY end
Dec 31
Incorporated
DE
Entity type
Operating
EIN
813467528
Phone
+1 617-714-6500
Business address
325 BINNEY STREET, CAMBRIDGE, MA, 02142
Former names
Moderna Therapeutics, Inc.
Open-market buys, last 90 days
$0
in 0 filings
Open-market sales, last 90 days
$50,775,837
in 5 filings, $50.8M under 10b5-1 plans

Net −$50,775,837. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.

Date Insider Transaction Shares Price Value Owned after
2023-03-15 Bancel Stephane Chief Executive Officer Exercise or conversion +40,000 $0.99 $40K 5,451,946
2023-03-15 Bancel Stephane Chief Executive Officer Sale −15,472 $148.33 $2.3M 5,436,474
2023-03-15 Bancel Stephane Chief Executive Officer Sale −22,481 $149.03 $3.4M 5,413,993
2023-03-15 Bancel Stephane Chief Executive Officer Sale −1,847 $150.00 $277K 5,412,146
2023-03-15 Bancel Stephane Chief Executive Officer Sale −200 $150.72 $30K 5,411,946
2023-03-15 Bancel Stephane Chief Executive Officer Exercise or conversion · Stock Option (Right to Buy) −40,000 1,187,155
2023-03-09 Bancel Stephane Chief Executive Officer Exercise or conversion +40,000 $0.99 $40K 5,451,946
2023-03-09 Bancel Stephane Chief Executive Officer Sale −11,461 $137.25 $1.6M 5,440,485
2023-03-09 Bancel Stephane Chief Executive Officer Sale −7,739 $137.97 $1.1M 5,432,746
2023-03-09 Bancel Stephane Chief Executive Officer Sale −3,896 $139.24 $542K 5,428,850
2023-03-09 Bancel Stephane Chief Executive Officer Sale −5,563 $140.23 $780K 5,423,287
2023-03-09 Bancel Stephane Chief Executive Officer Sale −9,232 $141.30 $1.3M 5,414,055
2023-03-09 Bancel Stephane Chief Executive Officer Sale −2,109 $142.26 $300K 5,411,946
2023-03-09 Bancel Stephane Chief Executive Officer Exercise or conversion · Stock Option (Right to Buy) −40,000 1,227,155
2023-03-08 Bancel Stephane Chief Executive Officer Exercise or conversion +40,000 $0.99 $40K 5,451,946
2023-03-08 Bancel Stephane Chief Executive Officer Sale −26,018 $141.18 $3.7M 5,425,928
2023-03-08 Bancel Stephane Chief Executive Officer Sale −13,982 $141.76 $2.0M 5,411,946
2023-03-08 Bancel Stephane Chief Executive Officer Exercise or conversion · Stock Option (Right to Buy) −40,000 1,267,155
2023-03-08 Klinger Shannon Thyme Chief Legal Officer Sale −561 $141.51 $79K 5,820
2023-03-07 Klinger Shannon Thyme Chief Legal Officer Exercise or conversion +1,138 6,381

Page 53 of 66 · 1,314 trades